Advertisement
Advanced Search

Share this page

KDIGO CKD-MBD Guideline Update

We’re pleased to share the KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Please see the Executive Summary and Full Guideline Update!
    • Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network

      Christoph Aufricht, Robert Beelen, Matthias Eberl, Michel Fischbach, Donald Fraser, Achim Jörres, Klaus Kratochwill, Manuel LópezCabrera, Peter Rutherford, Claus-Peter Schmitt, Nicholas Topley, Janusz Witowski
      DOI: http://dx.doi.org/10.1016/j.kint.2017.02.037
      Publication stage: In Press Corrected Proof
      Kidney International
    • MicroRNA-21 regulates peroxisome proliferator–activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4

      Sandra Chuppa, Mingyu Liang, Pengyuan Liu, Yong Liu, Marc C. Casati, Allen W. Cowley, Leah Patullo, Alison J. Kriegel
      DOI: http://dx.doi.org/10.1016/j.kint.2017.05.014
      Publication stage: In Press Corrected Proof
      Kidney International
    • Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats

      Juan M. Diaz-Tocados, Alan Peralta-Ramirez, María E. Rodríguez-Ortiz, Ana I. Raya, Ignacio Lopez, Carmen Pineda, Carmen Herencia, Addy Montes de Oca, Noemi Vergara, Sonja Steppan, M. Victoria Pendon-Ruiz de Mier, Paula Buendía, Andrés Carmona, Julia Carracedo, Juan F. Alcalá-Díaz, Joao Frazao, Julio M. Martínez-Moreno, Antonio Canalejo, Arnold Felsenfeld, Mariano Rodriguez, Escolástico Aguilera-Tejero, Yolanda Almadén, Juan R. Muñoz-Castañeda
      DOI: http://dx.doi.org/10.1016/j.kint.2017.04.011
      Publication stage: In Press Corrected Proof
      Kidney International
    • Retinoic acid improves nephrotoxic serum–induced glomerulonephritis through activation of podocyte retinoic acid receptor α

      Yan Dai, Anqun Chen, Ruijie Liu, Leyi Gu, Shuchita Sharma, Weijing Cai, Fadi Salem, David J. Salant, Jeffrey W. Pippin, Stuart J. Shankland, Marcus J. Moeller, Norbert B. Ghyselinck, Xiaquiang Ding, Peter Y. Chuang, Kyung Lee, John Cijiang He
      DOI: http://dx.doi.org/10.1016/j.kint.2017.04.026
      Publication stage: In Press Corrected Proof
      Kidney International
    • Impairment of the carnitine/organic cation transporter 1–ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease

      Yasuyuki Shinozaki, Kengo Furuichi, Tadashi Toyama, Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Shuichi Kaneko, Noriyoshi Isozumi, Shushi Nagamori, Yoshikatsu Kanai, Tomoko Sugiura, Yukio Kato, Takashi Wada
      DOI: http://dx.doi.org/10.1016/j.kint.2017.04.032
      Publication stage: In Press Corrected Proof
      Kidney International
  • Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

    Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel, Masafumi Fukagawa, Charles A. Herzog, Linda McCann, Sharon M. Moe, Rukshana Shroff, Marcello A. Tonelli, Nigel D. Toussaint, Marc G. Vervloet, Mary B. Leonard
    DOI: http://dx.doi.org/10.1016/j.kint.2017.04.006
    Kidney International, Vol. 92, Issue 1, p26–36
    Open Access
  • Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury

    Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly
    DOI: http://dx.doi.org/10.1016/j.kint.2016.12.021
    Kidney International, Vol. 91, Issue 6, p1482–1494
    Open Access
  • Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury

    Simon Sawhney, Angharad Marks, Nick Fluck, Adeera Levin, David McLernon, Gordon Prescott, Corri Black
    DOI: http://dx.doi.org/10.1016/j.kint.2017.02.019
    Kidney International, Vol. 92, Issue 2, p440–452
    Open Access
  • Obesity and kidney disease: from population to basic science and the search for new therapeutic targets

    Adam Whaley-Connell, James R. Sowers
    DOI: http://dx.doi.org/10.1016/j.kint.2016.12.034
    Kidney International, Vol. 92, Issue 2, p313–323
  • Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes

    Penelope J. Allen, Steve J. Chadban, Jonathan C. Craig, Wai H. Lim, Richard D.M. Allen, Philip A. Clayton, Armando Teixeira-Pinto, Germaine Wong
    DOI: http://dx.doi.org/10.1016/j.kint.2017.03.015
    Kidney International, Vol. 92, Issue 2, p461–469


Nobel Prize for Medicine 2016 awarded to Professor Ohsumi of Japan for his discovery of the molecular and cell biological pathways of autophagy.

Autophagy has been shown to be an essential mechanism by which cells remove defective molecular and cell organelle components, thereby renewing themselves constantly and especially after cell injury. Dysfunction of this pathway has since been shown to be important in the development of many acute and chronic degenerative diseases, including AKI and CKD. This has been reviewed recently in KI,

Autophagy in Acute Kidney Injury by Kaushal and Shah
Autophagy in Kidney Disease and Aging: Lessons from Rodent Models by Lenoir, Tharaux, and Huber.

and continues to be at the forefront of research directed at the pathophysiology and potential novel avenues of therapeutic interventions for kidney diseases.



With the January 2016 issue, Elsevier will be the official publisher of Kidney International, an official publication of the International Society of Nephrology. Read the full press release.

I am delighted that ISN managed to find a great publisher in Elsevier. Considering the big changes happening in the field of medical publishing, it is very reassuring that Kidney International is such an attractive journal to Elsevier. ISN is proud to have such an important pillar to its leading Global Education portfolio, currently delivering tailored education to a broad range of kidney professionals worldwide, through publications, meetings and a content-rich online portal.

David Harris, ISN Global Education Director


About KI

Kidney International (KI) is the official journal of the International Society of Nephrology. Under the editorial leadership of Dr. Detlef O. Schlöndorff (USA), KI is one of the most cited journals in nephrology and widely regarded as the world's premier journal on the development and consequences of kidney disease.

KI is peer-reviewed and publishes original research in both basic science and clinical medicine. These include the latest clinical studies on emerging developments in renal medicine and the highest level of original research studies in therapy and epidemiology of acute and chronic kidney failure, as well as their translational aspects and genetic basis. In addition relevant aspects of renal physiology, cell biology, biochemistry, pathology, immunology, morphology and new technological developments are reported with the over-all aim of informing the renal researcher and the practicing nephrologist on all aspects of renal research.

The journal reflects the field through critical reviews and original articles, commentaries, editorial updates on recent developments and news features, recommendations and guidelines resulting from expert consensus meetings, aspects of nephrology from the developing world, policy issues, remarkable images, and problem-focused articles for the diagnosis and treatment of renal patients. Kidney International is published monthly.
More

About the International Society of Nephrology

ISN

The International Society of Nephrology (ISN) is advancing kidney care worldwide. Through our scientific and capacity-building activities in advocacy, education and research, we bridge gaps in global kidney care, engaging in a collaborative effort to improve kidney disease prevention, diagnosis and treatment.

With over 9,000 professional members from over 150 countries, the ISN represents a wide international network and an efficient platform for timely scientific exchange, debate and communication between healthcare professionals involved in preventing and treating kidney disease.

By collaborating with more than 90 national and regional societies, we reach out to an additional 30,000 health professionals globally. Our overarching purpose is to tackle the global burden of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD), improving patient care through an interconnected advocacy, education and research strategy.

Current Issue

August 2017
Volume 92, Issue 2

List of Issues

Supports Open Access


This journal has an open archive

Learn more about open access options.


Journal Metrics

8.395
2016
Impact Factor

4/76
Urology &
Nephrology


KI Supplements

Our companion journal, KI Supplements, focuses on sponsored, topical content of interest to the nephrology community. The journal is complimentary to KI subscribers.

2016 Impact Factor is 5.593

KI Reports

We're pleased to announce the launch of KI Reports, a peer reviewed, open access journal devoted to the publication of leading research and developments related to kidney disease.

Submit your article today!